MedPath
HSA Approval

APO-DICLO SR TABLET 100 mg

SIN08993P

APO-DICLO SR TABLET 100 mg

APO-DICLO SR TABLET 100 mg

November 2, 1996

PHARMAFORTE SINGAPORE PTE LTD

PHARMAFORTE SINGAPORE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPHARMAFORTE SINGAPORE PTE LTD
Licence HolderPHARMAFORTE SINGAPORE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

M01AB05

diclofenac

Manufacturer Information

PHARMAFORTE SINGAPORE PTE LTD

APOTEX INC

Apotex Inc

Active Ingredients

Diclofenac sodium

100.0 mg

Diclofenac

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

APO-DICLO SR TABLET 100 mg - HSA Approval | MedPath